Pliant Therapeutics
PLRX
$15.27
Share price
-2.18%
Change (1 day)
-29.08%
Change (1 year)
Categories
P/S ratio for Pliant Therapeutics (PLRX)
P/S ratio as of May 2024 (TTM): 596
According to Pliant Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 596.004. At the end of 2023 the company had a P/S ratio of 687.
P/S ratio history for Pliant Therapeutics from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 687 | 605.45% |
| 2022 | 97.3 | 51.27% |
| 2021 | 64.3 | 233.04% |
| 2020 | 19.3 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.05 | -99.82% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | -84.48% | 🇺🇸 USA |